Travere Therapeutics Insider Sold Shares Worth $13,135,397, According to a Recent SEC Filing

MT newswire2026/09/18 07:42

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

03:42 AM EDT, 09/18/2026 (MT Newswires) -- William E. Rote, Chief Research Officer, on September 15, 2026, sold 209,048 shares in Travere Therapeutics (TVTX) for $13,135,397. Following the Form 4 filing with the SEC, Rote has control over a total of 98,197 common shares of the company, with 98,197 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1438533/000169826226000005/xslF345X05/form4-09182026_010952.xml

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Travere Therapeutics Insider Sold Shares Worth $13,135,397, According to a Recent SEC Filing

You may also like

Crypto prices